Monte Rosa Therapeutics, Inc. (GLUE)

Every official Monte Rosa Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Monte Rosa Therapeutics, Inc. documents

• Monte Rosa Therapeutics, Inc. 10-K 2026GLUE 10-K 2026: annual report for fiscal 2026
• Monte Rosa Therapeutics, Inc. 10-K 2025GLUE 10-K 2025: annual report for fiscal 2025
• Monte Rosa Therapeutics, Inc. 10-K 2024GLUE 10-K 2024: annual report for fiscal 2024
• Monte Rosa Therapeutics, Inc. 10-K 2023GLUE 10-K 2023: annual report for fiscal 2023
• Monte Rosa Therapeutics, Inc. 10-K 2022GLUE 10-K 2022: annual report for fiscal 2022
• Monte Rosa Therapeutics, Inc. 10-Q 2026GLUE 10-Q 2026: quarterly report for fiscal 2026
• Monte Rosa Therapeutics, Inc. 10-Q 2025GLUE 10-Q 2025: quarterly report for fiscal 2025
• Monte Rosa Therapeutics, Inc. 10-Q 2024GLUE 10-Q 2024: quarterly report for fiscal 2024
• Monte Rosa Therapeutics, Inc. 10-Q 2023GLUE 10-Q 2023: quarterly report for fiscal 2023
• Monte Rosa Therapeutics, Inc. 10-Q 2022GLUE 10-Q 2022: quarterly report for fiscal 2022
• Monte Rosa Therapeutics, Inc. 8-K 2026GLUE 8-K 2026: current report for fiscal 2026
• Monte Rosa Therapeutics, Inc. 8-K 2025GLUE 8-K 2025: current report for fiscal 2025
• Monte Rosa Therapeutics, Inc. 8-K 2024GLUE 8-K 2024: current report for fiscal 2024
• Monte Rosa Therapeutics, Inc. 8-K 2023GLUE 8-K 2023: current report for fiscal 2023
• Monte Rosa Therapeutics, Inc. 8-K 2022GLUE 8-K 2022: current report for fiscal 2022
• Monte Rosa Therapeutics, Inc. DEF 14A 2026GLUE DEF 14A 2026: proxy statement for fiscal 2026
• Monte Rosa Therapeutics, Inc. DEF 14A 2025GLUE DEF 14A 2025: proxy statement for fiscal 2025
• Monte Rosa Therapeutics, Inc. DEF 14A 2024GLUE DEF 14A 2024: proxy statement for fiscal 2024
• Monte Rosa Therapeutics, Inc. DEF 14A 2023GLUE DEF 14A 2023: proxy statement for fiscal 2023
• Monte Rosa Therapeutics, Inc. DEF 14A 2022GLUE DEF 14A 2022: proxy statement for fiscal 2022
• Monte Rosa Therapeutics, Inc. Form 4 2026GLUE Form 4 2026: insider trading filing for fiscal 2026
• Monte Rosa Therapeutics, Inc. Form 4 2025GLUE Form 4 2025: insider trading filing for fiscal 2025
• Monte Rosa Therapeutics, Inc. Form 4 2024GLUE Form 4 2024: insider trading filing for fiscal 2024
• Monte Rosa Therapeutics, Inc. Form 4 2023GLUE Form 4 2023: insider trading filing for fiscal 2023
• Monte Rosa Therapeutics, Inc. Form 4 2022GLUE Form 4 2022: insider trading filing for fiscal 2022
• Monte Rosa Therapeutics, Inc. S-1 2026GLUE S-1 2026: registration statement for fiscal 2026
• Monte Rosa Therapeutics, Inc. S-1 2025GLUE S-1 2025: registration statement for fiscal 2025
• Monte Rosa Therapeutics, Inc. S-1 2024GLUE S-1 2024: registration statement for fiscal 2024
• Monte Rosa Therapeutics, Inc. S-1 2023GLUE S-1 2023: registration statement for fiscal 2023
• Monte Rosa Therapeutics, Inc. S-1 2022GLUE S-1 2022: registration statement for fiscal 2022
• Monte Rosa Therapeutics, Inc. 13F 2026GLUE 13F 2026: institutional holdings for fiscal 2026
• Monte Rosa Therapeutics, Inc. 13F 2025GLUE 13F 2025: institutional holdings for fiscal 2025
• Monte Rosa Therapeutics, Inc. 13F 2024GLUE 13F 2024: institutional holdings for fiscal 2024
• Monte Rosa Therapeutics, Inc. 13F 2023GLUE 13F 2023: institutional holdings for fiscal 2023
• Monte Rosa Therapeutics, Inc. 13F 2022GLUE 13F 2022: institutional holdings for fiscal 2022

More companies